US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist
  • 3.290
  • -0.130-3.80%
Close Jun 20 16:00 ET
  • 3.290
  • 0.0000.00%
Post 19:49 ET
495.65MMarket Cap-5981P/E (TTM)

About Heron Therapeutics Company

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.

Company Profile

SymbolHRTX
Company NameHeron Therapeutics
Listing DateJan 23, 2014
Issue Price7.00
Founded1983
CEOMr. Craig A. Collard
MarketNASDAQ
Employees126
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4242 Campus Point Court,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-251-4400
Websitehttp://www.herontx.com

Company Executives

  • Name
  • Position
  • Salary
  • Craig A. Collard
  • Director and Chief Executive Officer
  • 10.78M
  • Ira Duarte
  • Chief Accounting Officer, Executive Vice President and Chief Financial Officer
  • 1.53M
  • Dr. William P. Forbes
  • Executive Vice President and Chief Development Officer
  • 1.46M
  • Adam Morgan
  • Chairman of the Board
  • 545.53K
  • Craig A. Johnson
  • Independent Director
  • 79.03K
  • Susan Rodriguez
  • Independent Director
  • 65.63K
  • Christian Waage
  • Independent Director
  • 70.51K
  • Dr. Sharmila Dissanaike, F.A.C.S.,M.D.
  • Independent Director
  • 55.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg